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Summary
The leukodystrophies form a complex group of orphan
genetic disorders that primarily affect myelin, the main
constituent of the brain white matter. Among the leu-
kodystrophies of undetermined etiology, a new clinical
entity called “vacuoliting megalencephalic leukoence-
phalopathy” (VL) was recently recognized. VL is char-
acterized by diffuse swelling of the white matter, large
subcortical cysts, and megalencephaly with infantile on-
set. Family studies in several ethnic groups have sug-
gested an autosomal recessive mode of inheritance. We
mapped the VL gene to chromosome 22qtel, within a 3-
cM linkage interval between markers D22S1161 and
n66c4 (maximum LOD score 10.12 at recombination
fraction .0, for marker n66c4; maximum multipoint
LOD score 17 for this interval) by genome scan of 13
Turkish families. Linkage analysis under the genetic-het-
erogeneity hypothesis showed no genetic heterogeneity.
No abnormalities were found in three tested candidate
genes (fibulin-1 and glutathione S-transferases 1 and 2).
The leukodystrophies are a heterogeneous group of or-
phan genetic disorders that primarily affect the white
matter of the brain and its main constituent, myelin.
Among the leukodystrophies of undetermined etiology,
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a new clinical entity called “vacuoliting megalencephalic
leukoencephalopathy” (VL) [MIM 604004] recently has
been recognized. This disorder is distinct from the other
leukodystrophies (i.e., Canavan disease [MIM 271900],
Alexander disease [MIM 203450], and GM1 ganglios-
idosis [MIM 230500]) that exhibit progressive mega-
lencephaly. VL is characterized by a milder clinical
course, which contrasts with severe abnormalities on
magnetic-resonance-imaging analysis of the brain. The
supratentorial hemispherical white matter appears dif-
fusely swelled, with bilateral subcortical cysts of typical
temporal location, whereas the gray-matter structures
are preserved (van der Knaap et al. 1995; Goutieres et
al. 1996; Singhal et al. 1996; Mejaski-Bosnjak et al.
1997; Topc¸u et al. 1998). Consanguinity between the
parents of VL-affected children, which is suggestive of
an autosomal recessive mode of inheritance, has been
observed in several ethnic groups. We report the local-
ization of the VL gene to chromosome 22qtel, by genome
scan of 10 consanguineous families and 3 families with
no known relationship that originated from rural areas
of central and southeastern Anatolia, in Turkey.
The study was approved by the review board of Hac-
ettepe University, Faculty of Medicine (Ankara). In-
formed consent was obtained from family members.
Twenty-one patients (9 boys and 12 girls) from 13
different families were analyzed. Consanguinity was
known to have occurred in 10 families. Clinical and
neurobiological features of 12 patients (from families
MEG1, MEG3, MEG 4, MEG 6, MEG8, and MEG10)
have been reported elsewhere (Topc¸u et al. 1998). The
diagnostic criteria for selection of the other families were
identical. All other causes of leukodystrophies have been
ruled out by an extensive biochemical analysis, including
quantitation of lysosomal activities (of b-hexosamini-
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Table 1
Two-Point Linkage-Analysis Data, from an Autosomal Recessive
Model with Full Penetrance
MARKER
LOD SCORE AT v =
Zmax vmax.00 .1 .2 .3 .4
D22S294   1.50 1.41 .93 .41 1.55 .132
D22S1170   2.99 2.00 1.00 .32 3.10 .069
D22S1161   6.01 4.05 2.30 .92 7.04 .026
D22S922 5.17 4.54 3.12 1.83 .76 5.47 .017
D22S1169 8.57 7.03 4.67 2.61 1.04 8.76 .010
ARSA 6.34 4.48 2.83 1.52 .58 6.34 .000
n66c4 10.12 7.41 4.84 2.64 .97 10.12 .000
dase, arylsulfatase A, b-galactosidase, and galactocere-
brosidase b-galactoside).
Because biochemical and enzymatic studies revealed
no known abnormalities, and because the high degree
of consanguinity between the parents of affected chil-
dren suggested an autosomal recessive mode of inheri-
tance, we undertook a genome scan to map the VL gene.
DNA was isolated and purified from peripheral blood,
by use of standard protocols. Genotyping was performed
with fluorescent end-labeled microsatellite markers from
the Ge´ne´thon map (Vignal et al. 1993). Alleles were
separated by electrophoresis performed with ABI 373
sequencers. Genotyping data were processed with GEN-
OTYPER (ABI), GENSCAN (ABI), and MARKSYN
(Ge´ne´thon) software. Two-point LOD-score analysis
was conducted with the FASTLINK program (Schaffer
1996), and multipoint LOD-score analysis was con-
ducted with the GENEHUNTER program (Kruglyak et
al. 1996); and an autosomal recessive mode of inheri-
tance with full penetrance and true marker-allele fre-
quencies was assumed. The disease-allele frequency was
set to .0001. This initial genome screening with the nine
initially collected families (Topc¸u et al. 1998) genotyped
with 257 fluorescent end-labeled microsatellite Ge´ne´-
thon markers spaced at an average distance of 14 cM
(Weissenbach et al. 1992; Dib et al. 1996) failed to reveal
linkage. A second genome search, with 300 additional
microsatellite markers (average spacing for the com-
bined set of markers was 6.5 cM), was therefore per-
formed. Linkage analysis of D22S1160 and D22S1169,
two markers separated by 11 cM, yielded a multipoint
LOD score of 4. Four additional Turkish families
(MEG13, MEG14, MEG15, and MEG16) were col-
lected, and the complete set of families was genotyped
with four new Ge´ne´thon markers. Multipoint linkage
analysis yielded a Zmax of 15. However, although mark-
ers showed homozygosity (Lander and Botstein 1987)
with fully informative families, several families remained
partially or totally uninformative, raising the possibility
of genetic heterogeneity.
To increase informativity of these families, new mi-
crosatellite markers were developed. Sequences of ge-
nomic clones spanning the telomeric region that were
downloaded from The Sanger Center were computer
scanned for short tandem repeats. Three microsatellite
sequences were identified, two in the vicinity of the genes
encoding fibulin (FBLN-1) and arylsulfatase A (ARSA)
and one in the genomic clone n66c4. New markers were
developed, and the 13 families were genotyped. Primer
sets flanking the microsatellite motifs were developed for
FBLN1D/(CA)n (FBLN-1 [GenBank accession number
Z95331] [motif: CA repeat, primer set GACCTACTA-
TGTGCCAGGAAGG and GGCTGAGGCACAAGAG-
TTTC, size 300–300 bp]), ARSA(CT)n (ARSA [Genbank
accession number U62317] [motif: CT repeat, primer set
CCGGCCAAAAATGACTTTTA and CTGGAAAGAG-
CAAGACCCTG, size 200–204 bp]), and n66c4 clone
[Genbank accession number AC000050] [motif: CA re-
peat, primer set ACTCATCGCATACACTGTGTCC and
CAGGGTGGATCACCAAGC, size: 266–274 bp]). The
allele size was estimated by use of individual 134702
from the CEPH reference family. Two-point linkage
analysis yielded a maximum LOD score (Zmax) of 10.12
at a recombination fraction (v) of 0, for marker n66c4
(table 1). This result is in agreement with the results of
two-point linkage simulation (autosomal recessive mode
of inheritance, full penetrance, five isofrequent marker
alleles, and disease-allele frequency .0001), performed
with SLINK (Weeks et al. 1990), which yielded an av-
erage LOD score of 10 at for this family set.v = .0
Multipoint linkage analysis performed with GENE-
HUNTER (Kruglyak et al. 1996) yielded a Zmax of 17
(fig. 1). This result was confirmed by haplotype con-
struction with D22S294, D22S1170, D22S1161,
D22S922, D22S1169, ARSA/(CT)n, and n66c4/(CA)n,
which places the VL gene within a 3-cM linkage interval
defined by D22S1161 (proximal) and n66c4 (distal) (fig.
2). The map is based on the recently published sequence
of chromosome 22 (Dunham et al. 1999). Multipoint
linkage analysis performed under the heterogeneity hy-
pothesis revealed no genetic heterogeneity (data not
shown).
Three affected children were born from three mar-
riages that had no known consanguinity (i.e., families
MEG6, MEG11, and MEG16). Haplotype analysis of
family MEG11 showed an 11-cM homozygosity region,
suggesting that the parents were likely to be related.
Results showed no homozygosity for the affected child
in each of families MEG6 and MEG16. However, anal-
ysis of the extended haplotypes showed that the unaf-
fected siblings had inherited different combinations of
recombinant haplotypes (fig. 2). Taken together, these
results show that VL is linked to a single locus that spans
a 3-cM region located on chromosome 22qtel. Whereas
this rare disorder was mapped in a set of Turkish families
originating from small villages in a rural area, a founder
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Figure 1 Graphic representation of multipoint LOD-score analysis of the 22qtel chromosomal region linked to the VL gene. The multipoint
LOD score was computed with GENEHUNTER (Kruglyak et al. 1996) by use of a recessive mode of inheritance, complete penetrance, and
true marker-allele frequencies. The disease-allele frequency was set to .0001.
effect that would be revealed by a common haplotype
was anticipated. However, within the limits of the an-
alyzed markers, haplotype analysis did not confirm this
hypothesis.
Three candidate genes—fibulin-1 (Argraves et al.
1989) and glutathione S-transferases 1 GSTT1 (Pemble
et al. 1994) and 2 GSTT2 (Tan et al. 1995)—that
mapped within the initial linkage interval were analyzed
for their potential involvement in the disease etiology.
FBLN1D/(CA)n, physically mapped between D22S1141
and D22S1170, revealed three recombination events. Se-
quence analysis of GSTT1 and GSTT2 revealed no se-
quence variations. Therefore, FBLN1, GSTT1, and
GSTT2 were excluded.

Figure 2 Haplotypes of seven 22qtel DNA markers defining the shortest linkage interval derived from 10 consanguineous families and from 3 families with no known relationship. Haplotypes
were inferred by use of GENEHUNTER (Kruglyak et al. 1996). Disease haplotypes are enclosed within ovals. Missing genotypes are indicated by hyphens (-), and recombination events are indicated
by “#”. Physical position (in Mb) of the markers along the chromosome is indicated next to the marker names (Dunham et al. 1999).
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We mapped the VL gene to chromosome 22qtel, within
a 3-cM linkage interval between D22S1161 and n66c4,
by genome scan and fine mapping. This result was sup-
ported by a two-point LOD score ( atZ = 10.12max
, for marker n66c4) and by a mul-maximum v [v] = .0
tipoint LOD score of 17 for the interval between
D22S1161 and n66c4. Haplotype analysis of the three
affected children born from marriages between parents
of unknown relationship (families MEG6, MEG11, and
MEG16) showed extended homozygosity for family
MEG11, suggesting that the parents are likely to be
related.
Although consanguinity is expected to permit gene
mapping with a limited number of families, the mapping
of the VL gene proved to be difficult. To reveal linkage,
we had to increase the marker density of our genome
scan. This was probably because of lack of informativity
of the markers, rather than because of clinical hetero-
geneity. In contrast, several factors are likely to be re-
sponsible for the difficulties that we encountered. First,
approximately half of the parents were distant cousins.
Therefore, the chromosomal region homozygous by de-
scent was expected be small. Second, these families orig-
inated from a population in which ∼30% of the mar-
riages are consanguineous. The number of observed
heterozygotes was approximately half of what would be
expected on the basis of marker PIC values. Therefore,
consanguinity reduces marker informativity by limiting
the allele number. Third, the VL gene mapped to the
telomeric end of the long arm of chromosome 22, a
region with poor marker coverage. Fourth, the size of
the chromosomal region shared by the affected children
appeared to be small (i.e., 3 cM).
Although the families originated from rural areas of
central and southeastern Anatolia, in Turkey, no shared
allele or shared haplotype was detected. This suggests
either that the genetic markers are still too far from the
disease gene to allow detection of an ancient founder
effect or the existence of allelic heterogeneity.
Although mild and severe forms of the disease were
noted, both forms appeared to be linked to the same
locus. The clinical variations could actually be due either
to nongenetic factors or to modifier genes that affect the
phenotype and the course of the disease.
In an attempt to identify the disease gene, we analyzed
three candidate genes—FBLN-1, GSTT1, and GSTT2.
A microsatellite marker located 3′ to FBLN-1 was de-
veloped. Three families showed recombination events
that excluded this gene. GSTT1 and GSTT2 were an-
alyzed by PCR amplification and exon sequencing. PCR
analysis showed a higher frequency of deletion of the
GSTT1 gene than previously had been reported (59%
vs. 38%). However, sequence variations in the two
GSTT genes were not observed.
At present, we are attempting the positional cloning
of the VL gene, to determine the underlying mechanism
of this disorder. A search of the GeneMap’99 database
for the D22S1161-22qtel region revealed 30 expressed
sequence tags (ESTs). Development of new microsatel-
lites or single-nucleotide-polymorphism markers would
help to further define both the linkage interval and the
number of ESTs necessary to screen for mutations.
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